156 related articles for article (PubMed ID: 26071332)
1. Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation.
Moal V; Motte A; Vacher-Coponat H; Tamalet C; Berland Y; Colson P
J Clin Virol; 2015 Jul; 68():32-6. PubMed ID: 26071332
[TBL] [Abstract][Full Text] [Related]
2. Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea.
Lee KH; Shim KS; Lim IS; Chae SA; Yun SW; Lee NM; Choi YB; Yi DY
BMC Pediatr; 2017 Jul; 17(1):164. PubMed ID: 28705230
[TBL] [Abstract][Full Text] [Related]
3. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of hepatitis B vaccination in healthcare workers of Oil Company Hospital, Tehran, Iran (1989-2005).
Alavian SM; Mansouri S; Abouzari M; Assari S; Bonab MS; Miri SM
Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):131-4. PubMed ID: 18188034
[TBL] [Abstract][Full Text] [Related]
5. Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study.
Chancharoenthana W; Leelahavanichkul A; Udomkarnjananun S; Wattanatorn S; Avihingsanon Y; Praditpornsilpa K; Tungsanga K; Eiam-Ong S; Townamchai N
Open Forum Infect Dis; 2019 Jan; 6(1):ofy342. PubMed ID: 30697573
[TBL] [Abstract][Full Text] [Related]
6. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
8. [Are teenagers immunized in infancy still protected against hepatitis B?].
Pokorska-Lis M; Marczyńska M
Przegl Lek; 2010; 67(1):13-7. PubMed ID: 20509565
[TBL] [Abstract][Full Text] [Related]
9. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
[TBL] [Abstract][Full Text] [Related]
10. Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients.
Charpin C; Guis S; Colson P; Borentain P; Mattéi JP; Alcaraz P; Balandraud N; Thomachot B; Roudier J; Gérolami R
Arthritis Res Ther; 2009; 11(6):R179. PubMed ID: 19941642
[TBL] [Abstract][Full Text] [Related]
11. The risks of HBV infection after liver transplantation from HBc antibody positive donor to HBs antibody positive recipient.
Ikegami T; Taketomi A; Ohta R; Soejima Y; Yoshizumi T; Harada N; Shimada M; Maehara Y
Hepatogastroenterology; 2008; 55(88):2162-5. PubMed ID: 19260497
[TBL] [Abstract][Full Text] [Related]
12. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
[TBL] [Abstract][Full Text] [Related]
14. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population.
Charest AF; Grand'Maison A; McDougall J; Goldstein MB
Am J Kidney Dis; 2003 Dec; 42(6):1193-9. PubMed ID: 14655191
[TBL] [Abstract][Full Text] [Related]
15. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
[TBL] [Abstract][Full Text] [Related]
16. Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient.
Sobhonslidsuk A; Sornmayura P; Sumethkul V
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S257-61. PubMed ID: 17044481
[TBL] [Abstract][Full Text] [Related]
17. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
[TBL] [Abstract][Full Text] [Related]
18. [Reactivation of hepatitis B virus after autologous peripheral blood stem cell transplantation in patients with positive hepatitis B surface antibodies].
Endo T; Sawada K; Fujimoto K; Yamamoto S; Takashima H; Haseyama Y; Nishio M; Koizumi K; Koike T
Rinsho Ketsueki; 2000 Apr; 41(4):322-8. PubMed ID: 10846463
[TBL] [Abstract][Full Text] [Related]
19. Titers of antibodies to the surface antigen of hepatitis B virus after vaccination in relation to immunity-related gene variants. A prospective study among hemodialysis patients.
Jodłowska-Siewert E; Jagodziński PP; Grzegorzewska AE
Pol Arch Intern Med; 2017 Aug; 127(7-8):481-489. PubMed ID: 28817541
[TBL] [Abstract][Full Text] [Related]
20. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
Tien YC; Yen HH; Li CF; Liu MP; Hsue YT; Hung MH; Chiu YM
Arthritis Res Ther; 2018 Nov; 20(1):246. PubMed ID: 30382902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]